Latest Bone tumor Stories
PINEHURST, N.C., Jan.
DENVER, Oct. 9, 2014 /PRNewswire-USNewswire/ -- The Limb Preservation Foundation has announced the completion of funding for the Ross M. Wilkins, M.D.
Rhode Island Hospital researchers have found that the absence of the Shp-2 enzyme near specialized cartilage cells can lead to the development of multiple benign cartilage tumors in mice, a model that recapitulates the rare human tumor syndrome metachondromatosis.
Modern day exposure to pollution, toxins, radiation, and even unhealthy foods are considerable factors in the risk of future cancer. And because these factors are associated with modern society, it is especially rare to find cancers in older civilizations.
First-of-its-kind research presented today showed microwave ablation (MWA) therapy cut pain in half for patients with painful bone and soft-tissue tumors and took less time to complete than radiofrequency ablation.
Washington University in St. Louis Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine in St. Louis. The drugs, IAP antagonists, block survival signals that many cancer cells rely on to stay alive. Working in mice, the investigators found that targeting the same protein that makes...
Ewing’s sarcoma is a bone cancer commonly diagnosed in about 250 U.S. teenagers per year.